Annexon Ownership | Who Owns Annexon?

Overview Forecast RevenueFinancials Chart

Annexon Ownership Summary

Annexon is owned by 87.75% institutional investors, 0.50% insiders, and 11.75% retail investors. Bain capital life sciences investors is the largest institutional shareholder, holding 6.89% of ANNX shares. BB Biotech AG Ord is the top mutual fund, with 4.88% of its assets in Annexon shares.

ANNX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Annexon	87.75%	0.50%	11.75%
Sector	Healthcare Stocks	47.31%	8.01%	44.69%
Industry	Biotech Stocks	45.43%	7.81%	46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bain capital life sciences investors	8.45M	6.89%	$41.40M
Fmr	8.30M	6.77%	$40.67M
Alerce investment management	7.41M	6.04%	$36.29M
Bvf inc/il	7.00M	5.71%	$34.30M
Blackrock	6.59M	5.37%	$32.28M
Redmile group	6.43M	5.24%	$31.49M
Point72 asset management	5.99M	4.88%	$29.35M
Bellevue group	5.16M	4.20%	$25.27M
Vanguard group	4.56M	3.71%	$22.33M
Woodline partners lp	4.07M	3.32%	$19.95M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Alerce investment management	7.41M	71.13%	$36.29M
Bain capital life sciences investors	8.45M	4.55%	$41.40M
Redmile group	6.43M	1.90%	$31.49M
Tfg asset management gp	1.26M	1.54%	$6.16M
Bvf inc/il	7.00M	0.96%	$34.30M
Logos global management lp	1.50M	0.59%	$7.35M
Gmt capital	2.94M	0.53%	$14.41M
Rhenman & partners asset management ab	900.00K	0.42%	$4.41M
Bellevue group	5.16M	0.41%	$25.27M
Ghost tree capital	214.50K	0.33%	$1.05M

Top Buyers

Holder	Shares	% Assets	Change
Bellevue group	5.16M	0.41%	2.98M
Woodline partners lp	4.07M	0.19%	2.07M
Candriam s.c.a.	2.05M	0.06%	2.05M
Blackrock	6.59M	0.00%	1.54M
Marshall wace, llp	1.69M	0.01%	1.38M

Top Sellers

Holder	Shares	% Assets	Change
Octagon capital advisors lp	400.00K	0.31%	-1.65M
Pictet asset management sa	-	-	-1.64M
Adage capital partners gp	2.84M	0.03%	-1.48M
Fmr	8.30M	0.00%	-1.07M
Polar capital	-	-	-1.00M

New Positions

Holder	Shares	% Assets	Change	Value
Candriam s.c.a.	2.05M	0.06%	2.05M	$10.06M
Tfg asset management gp	1.26M	1.54%	1.26M	$6.16M
Rhenman & partners asset management ab	900.00K	0.42%	900.00K	$4.41M
Readystate asset management lp	883.45K	0.14%	883.45K	$4.33M
Mutual of america capital management	639.57K	0.03%	639.57K	$3.13M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-9.00
Quadrant capital group	-34.00
Parallel advisors	-122.00
Lindbrook capital	-290.00
Sunbelt securities	-800.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	157	16.30%	107,640,091	13.59%	87	1.47%	98	22.50%	32	14.29%
Mar 31, 2024	135	32.35%	94,758,161	17.52%	77	0.73%	80	42.86%	28	3.70%
Dec 31, 2023	102	5.15%	80,631,348	50.51%	103	2.04%	56	30.23%	27	-6.90%
Sep 30, 2023	97	-3.00%	53,570,888	-1.02%	71	1.37%	43	-34.85%	29	70.59%
Jun 30, 2023	100	-2.91%	54,125,210	0.30%	71	1.35%	66	8.20%	17	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
BB Biotech AG Ord	5.16M	4.88%	-
Vanguard Total Stock Mkt Idx Inv	2.83M	2.68%	-
iShares Russell 2000 ETF	2.47M	2.34%	-5.54K
Fidelity Growth Compy Commingled Pl S	2.39M	2.26%	13.38K
Fidelity Growth Compy Commingled Pl O	2.37M	2.25%	-
Candriam Eqs L Biotech C USD Cap	2.19M	2.08%	-
SPDR® S&P Biotech ETF	1.95M	1.85%	21.58K
Fidelity Growth Company Fund	1.78M	1.69%	-3.78K
Fidelity Small Cap Growth	1.33M	1.26%	-3.48K
Vanguard Institutional Extnd Mkt Idx Tr	1.30M	1.23%	237.44K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 15, 2024	Yednock Ted	EVP & CHIEF INNOVATION OFFICER	Sell	$40.07K
Oct 01, 2024	Carson William H.	-	Buy	$19.10K
Sep 19, 2024	Yednock Ted	EVP & CHIEF INNOVATION OFFICER	Sell	$31.95K
Sep 12, 2024	Yednock Ted	EVP & CHIEF INNOVATION OFFICER	Sell	$33.88K
Sep 05, 2024	Yednock Ted	EVP & CHIEF INNOVATION OFFICER	Sell	$31.02K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	1	1
2024 Q3	3	7
2024 Q2	3	-
2024 Q1	-	7
2023 Q4	1	2

ANNX Ownership FAQ

Who Owns Annexon?

Annexon shareholders are primarily institutional investors at 87.75%, followed by 0.50% insiders and 11.75% retail investors. The average institutional ownership in Annexon's industry, Biotech Stocks , is 45.43%, which Annexon exceeds.

Who owns the most shares of Annexon?

Annexon’s largest shareholders are Bain capital life sciences investors (8.45M shares, 6.89%), Fmr (8.3M shares, 6.77%), and Alerce investment management (7.41M shares, 6.04%). Together, they hold 19.69% of Annexon’s total shares outstanding.

Does Blackrock own Annexon?

Yes, BlackRock owns 5.37% of Annexon, totaling 6.59M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 32.28M$. In the last quarter, BlackRock increased its holdings by 1.54M shares, a 30.61% change.

Who is Annexon’s biggest shareholder by percentage of total assets invested?

Alerce investment management is Annexon’s biggest shareholder by percentage of total assets invested, with 71.13% of its assets in 7.41M Annexon shares, valued at 36.29M$.

Who is the top mutual fund holder of Annexon shares?

BB Biotech AG Ord is the top mutual fund holder of Annexon shares, with 4.88% of its total shares outstanding invested in 5.16M Annexon shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools